JPS5382792U - - Google Patents
Info
- Publication number
- JPS5382792U JPS5382792U JP16635976U JP16635976U JPS5382792U JP S5382792 U JPS5382792 U JP S5382792U JP 16635976 U JP16635976 U JP 16635976U JP 16635976 U JP16635976 U JP 16635976U JP S5382792 U JPS5382792 U JP S5382792U
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16635976U JPS5382792U (en) | 1976-12-10 | 1976-12-10 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16635976U JPS5382792U (en) | 1976-12-10 | 1976-12-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5382792U true JPS5382792U (en) | 1978-07-08 |
Family
ID=28774095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16635976U Pending JPS5382792U (en) | 1976-12-10 | 1976-12-10 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5382792U (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9387259B2 (en) | 2011-10-14 | 2016-07-12 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| US9399073B2 (en) | 2011-10-14 | 2016-07-26 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines |
| US9399641B2 (en) | 2011-09-20 | 2016-07-26 | Medimmune Limited | Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates |
| US9415117B2 (en) | 2012-10-12 | 2016-08-16 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| US9526798B2 (en) | 2011-10-14 | 2016-12-27 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| US9592240B2 (en) | 2010-04-15 | 2017-03-14 | Seattle Genetics Inc. | Targeted pyrrolobenzodiazapine conjugates |
| US11813335B2 (en) | 2017-02-08 | 2023-11-14 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| US11938192B2 (en) | 2017-06-14 | 2024-03-26 | Medimmune Limited | Dosage regimes for the administration of an anti-CD19 ADC |
-
1976
- 1976-12-10 JP JP16635976U patent/JPS5382792U/ja active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9592240B2 (en) | 2010-04-15 | 2017-03-14 | Seattle Genetics Inc. | Targeted pyrrolobenzodiazapine conjugates |
| US9399641B2 (en) | 2011-09-20 | 2016-07-26 | Medimmune Limited | Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates |
| US9387259B2 (en) | 2011-10-14 | 2016-07-12 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| US9399073B2 (en) | 2011-10-14 | 2016-07-26 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines |
| US9526798B2 (en) | 2011-10-14 | 2016-12-27 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| US9415117B2 (en) | 2012-10-12 | 2016-08-16 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| US11813335B2 (en) | 2017-02-08 | 2023-11-14 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| US11938192B2 (en) | 2017-06-14 | 2024-03-26 | Medimmune Limited | Dosage regimes for the administration of an anti-CD19 ADC |